Back

A specific complex I-induced ROS modulator, OP2113, is a new cardioproctective agent against acute myocardial infarction injuries during reperfusion.

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Acute coronary syndrome treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Aurelie Boucard

OP2 Drugs, Bordeaux (France)

12 More presentations in this session

Presentation thumbnail
Doctor A. Mishra (Sayre, US)
Abstract Slides
Presentation thumbnail
Doctor P. Azevedo (Faro, PT)
Abstract Slides
Presentation thumbnail
Doctor H. Tashiro (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Doctor Q. Deng (Wuhan, CN)
Presentation thumbnail
Professor R. Dabrowski (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Acute coronary syndrome treatment

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Characterization of cardiac effects of OPA1 protein promotion in transgenic animal model
28 August 2022
thumbnail
Congress Presentation
Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention
28 August 2020
thumbnail
Congress Presentation
Myeloperoxidase inhibitor AZD4831 target engagement and safety in a phase 2a study in patients with heart failure with preserved ejection fraction (SATELLITE)
1 July 2021
thumbnail
Congress Presentation
Identifying a cardioprotective agent using human quadricellular cardiovascular organoids for modelling chemotherapy-induced cardiomyopathy.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources